Results 101 to 110 of about 64,832 (295)

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin   +8 more
wiley   +1 more source

Acute emesis: moderately emetogenic chemotherapy [PDF]

open access: yes, 2010
This paper is a review of the recommendations for the prophylaxis of acute emesis induced by moderately emetogenic chemotherapy as concluded at the third Perugia Consensus Conference, which took place in June 2009.
Bria, Emilio   +6 more
core   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

open access: yesMed Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin   +8 more
wiley   +1 more source

PARP inhibition: a promising therapeutic target in ovarian cancer [PDF]

open access: yes, 2015
Ovarian cancer is burdened by the highest mortality rate among gynecological cancers. Gold standard is represented by the association of platinum-taxane -based chemotherapy and radical surgery.
Abdul Halim, T   +14 more
core   +1 more source

Economic evaluation of ondansetron: Preliminary analysis using clinical trial data prior to price setting [PDF]

open access: yes, 1992
This article has been made available through the Brunel Open Access Publishing Fund and is available from the specified link - Copyright © 1992 Macmillan Press Ltd.This study combines secondary analysis of efficacy and side-effect data from a randomised ...
Buxton, MJ, O'Brien, BJ
core   +1 more source

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

open access: yesAnnals of Oncology, 2017
Background Despite the availability of effective antiemetics and evidence-based guidelines, up to 40% of cancer patients receiving chemotherapy fail to achieve complete nausea and vomiting control.
G. Dranitsaris   +8 more
semanticscholar   +1 more source

Characterizing Difficulty and Life Disruption During B‐Acute Lymphoblastic Leukemia Therapy From the Perspective of Parents: A Survey Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Children with B‐acute lymphoblastic leukemia (B‐ALL) treated in resource‐intensive settings have a high likelihood of cure, but therapy is long, burdensome, and associated with substantial toxicities. Understanding parents’ perceptions of the most disruptive and difficult aspects of B‐ALL treatment is critical to future improvements in
Kellee N. Parker   +7 more
wiley   +1 more source

Renal cell carcinoma with atypical omental metastasis: A case report and literature review

open access: yesUroPrecision, EarlyView.
Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of ...
Andrew Jing   +4 more
wiley   +1 more source

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting in Italy: pharmacoeconomic and clinical aspects

open access: yesFarmeconomia: Health Economics and Therapeutic Pathways, 2007
Despite considerable improvements in the last two decades, chemotherapy-induced nausea and vomiting (CINV) remains a frequent and very bothersome medical problem.
Lorenzo Pradelli, Mario Eandi
doaj   +1 more source

Home - About - Disclaimer - Privacy